Amgen Inc (AMGN)
311.29
+32.90
(+11.82%)
USD |
NASDAQ |
May 03, 16:00
311.41
+0.12
(+0.04%)
After-Hours: 20:00
Amgen Cash from Investing (Quarterly): -217.00M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -217.00M |
December 31, 2023 | -27.09B |
September 30, 2023 | -262.00M |
June 30, 2023 | -211.00M |
March 31, 2023 | 1.358B |
December 31, 2022 | -3.473B |
September 30, 2022 | -267.00M |
June 30, 2022 | -2.193B |
March 31, 2022 | -111.00M |
December 31, 2021 | -230.00M |
September 30, 2021 | 73.00M |
June 30, 2021 | 1.209B |
March 31, 2021 | -319.00M |
December 31, 2020 | -1.384B |
September 30, 2020 | -1.628B |
June 30, 2020 | -2.159B |
March 31, 2020 | -230.00M |
December 31, 2019 | -5.963B |
September 30, 2019 | 5.372B |
June 30, 2019 | 2.745B |
March 31, 2019 | 3.555B |
December 31, 2018 | -4.637B |
September 30, 2018 | 1.132B |
June 30, 2018 | 2.938B |
March 31, 2018 | 14.91B |
Date | Value |
---|---|
December 31, 2017 | -78.00M |
September 30, 2017 | -1.976B |
June 30, 2017 | -1.813B |
March 31, 2017 | -157.00M |
December 31, 2016 | -1.222B |
September 30, 2016 | -2.389B |
June 30, 2016 | -657.00M |
March 31, 2016 | -4.39B |
December 31, 2015 | -233.00M |
September 30, 2015 | -2.003B |
June 30, 2015 | -2.359B |
March 31, 2015 | -952.00M |
December 31, 2014 | 374.00M |
September 30, 2014 | -2.903B |
June 30, 2014 | -2.458B |
March 31, 2014 | -765.00M |
December 31, 2013 | -10.12B |
September 30, 2013 | -2.119B |
June 30, 2013 | 1.959B |
March 31, 2013 | 1.809B |
December 31, 2012 | -2.031B |
September 30, 2012 | -3.173B |
June 30, 2012 | -2.44B |
March 31, 2012 | -2.346B |
December 31, 2011 | -220.00M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-27.09B
Minimum
Dec 2023
5.372B
Maximum
Sep 2019
-1.749B
Average
-246.00M
Median
Cash from Investing (Quarterly) Benchmarks
Gilead Sciences Inc | -2.207B |
Johnson & Johnson | -464.00M |
Eli Lilly and Co | -1.178B |
Merck & Co Inc | 53.00M |
Vertex Pharmaceuticals Inc | -886.50M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 689.00M |
Cash from Financing (Quarterly) | -1.708B |
Free Cash Flow | 7.098B |
Free Cash Flow Per Share (Quarterly) | 0.8563 |
Free Cash Flow to Equity (Quarterly) | 1.052B |
Free Cash Flow to Firm (Quarterly) | 1.828B |
Free Cash Flow Yield | 4.24% |